Related Experiment Video
Updated: Jun 3, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Depression and cardiac disease: a review
Christopher M Celano1, Jeff C Huffman
1Harvard Medical School, Boston, MA, USA. ccelano@partners.org
Insights
Depression significantly impacts cardiac patients, increasing mortality risk. Routine screening and treatment are recommended for better cardiac outcomes and patient well-being.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Depression affects 20%-40% of cardiac patients, leading to chronic symptoms.
- Depressive symptoms are linked to coronary artery disease progression, reduced quality of life, and increased mortality.
- Depression's physiological effects (inflammation, autonomic dysfunction) may worsen cardiac outcomes.
Purpose of the Study:
- To highlight the prevalence and impact of depression in cardiovascular disease patients.
- To emphasize the link between depression and adverse cardiac events.
- To advocate for routine depression screening and integrated management in cardiac care.
Main Methods:
- Literature review and synthesis of existing research on depression in cardiac populations.
- Analysis of the association between depressive symptoms and cardiovascular outcomes.
- Evaluation of treatment efficacy and screening tool availability.
Main Results:
- Depression is associated with a 2- to 2.5-fold increased mortality risk in cardiac patients.
- Impaired adherence and physiological changes mediate the link between depression and cardiac events.
- Pharmacologic and psychotherapeutic interventions show promise for symptom reduction and potential cardiac benefit.
Conclusions:
- Routine screening for depression in cardiac patients is crucial.
- Integrated care models with psychiatric consultation and care management are recommended.
- Timely recognition and treatment of depression can improve cardiac patient outcomes.
Abstract:
Depression is highly prevalent in cardiac patients, with 20% to 40% of patients meeting criteria for major depressive disorder or experiencing an elevation in depressive symptoms. These depressive symptoms are often chronic and persistent, and they have been associated with the development and progression of coronary artery disease, worse health-related quality of life, poor physical functioning, recurrent cardiac events, and a 2- to 2.5-fold increased risk of mortality. Impaired adherence to health behaviors and adverse physiological effects of depression, including inflammation, endothelial dysfunction, platelet hyperactivity, and autonomic nervous system abnormalities, may link depression with adverse cardiac outcomes. Pharmacologic and psychotherapeutic interventions appear to be safe and effective at reducing depressive symptoms in patients with cardiovascular disease and may impact cardiac outcomes. Unfortunately, depression often is unrecognized and untreated in this population, despite the availability of brief screening tools that can be used for this purpose. We recommend the routine screening of cardiac patients for depression when there are adequate mechanisms for management and referral, such as available consulting psychiatrists or care management programs that facilitate the delivery of pharmacologic and psychotherapeutic treatments in this vulnerable population.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Depression: Overview
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology